INTERCEPT PHARMACEUTICALS, INC. (21)

Browse by Contract Category

Contracts

Retirement and Consulting Agreement by and between Intercept Pharmaceuticals, Inc. and Mark Pruzanski, M.D., dated December 9, 2020 (Filed With SEC on December 10, 2020)
Form of Restricted Stock Unit Award Grant Notice and Agreement for Directors (Filed With SEC on August 10, 2020)
Letter Agreement, dated October 25, 2019, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 25, 2020)
Third Amendment to Lease, dated November 1, 2019, between the Registrant and Legacy Yards Tenant LP (Filed With SEC on November 5, 2019)
Amended and Restated Employment Agreement by and between Intercept Pharmaceuticals, Inc. and Jerome Durso, dated December 9, 2020 (Filed With SEC on December 10, 2020)
Employment Agreement, effective June 20, 2015, between the Registrant and Richard Kim (Filed With SEC on August 10, 2020)
Form of Stock Option Grant Notice and Agreement for Directors (Filed With SEC on August 10, 2020)
Form of Restricted Stock Unit Award Grant Notice and Agreement for Employees and Consultants (Filed With SEC on February 25, 2020)
Employment Agreement, effective November 19, 2019, between the Registrant and Jason Campagna (Filed With SEC on February 25, 2020)
Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on February 25, 2020)
Form of Stock Option Grant Notice and Agreement for Employees and Consultants (Filed With SEC on February 25, 2020)
Description of Securities of the Registrant (Filed With SEC on February 25, 2020)
Employment Agreement, effective February 6, 2018, between the Registrant and Gail Cawkwell (Filed With SEC on August 8, 2019)
Employment Agreement, effective January 22, 2018, between the Registrant and Ryan Sullivan (Filed With SEC on August 8, 2019)
Second Supplemental Indenture, dated as of May 14, 2019, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee (including the form of 2.00%... (Filed With SEC on May 14, 2019)
Securities Purchase Agreement, dated May 8, 2019, between Intercept Pharmaceuticals, Inc. and Samsara BioCapital, L.P (Filed With SEC on May 14, 2019)
Convertible Notes Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies... (Filed With SEC on May 14, 2019)
Common Stock Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC,... (Filed With SEC on May 14, 2019)
Form of Restricted Stock Unit Grant Notice and Agreement for Employees and Consultants (Filed With SEC on May 8, 2019)
Form of Performance Stock Unit Grant Notice and Agreement (Filed With SEC on May 8, 2019)
Form of Stock Option Grant Notice and Agreement for Employees and Consultants (Filed With SEC on May 8, 2019)